Inhibition of GCN2 Alleviates Alcoholic Liver Disease
To explore the potential of general control nonderepressible 2 (GCN2) as a therapeutic target for ALD, we first established an ALD model by feeding Gcn2 knockout mice and their wild-type (WT) littermates a Lieber-DeCarli ethanol-containing diet for 6 weeks.